BSE filing, NSE: SIS. Summary written from the filing by ALFA Finder's alert engine.
SIS Ltd: key numbers
- Share price
- ₹382.30
- Market cap
- ₹5,404 Cr
- Revenue (annual)
- ₹15,982 Cr
- Net profit (annual)
- ₹137.8 Cr
- P/E (TTM)
- 36.9×Sector 36.4×
- Promoter holding
- 71.84%-0.02% QoQ
- FII holding
- 14.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from SIS Ltd
All →SIS Board Meeting Date
SIS Ltd intimated that its Board is scheduled for 4 Nov 2026 to consider Q2/H1 FY27 results. Trading window closes 1 Oct–6 Nov 2026.
SIS Management Change
Mr. Vineet Toshniwal has resigned from his position as President (M&A and Investor Relations) at SIS Limited, effective January 31, 2027.
SIS Capital Structure Change
SIS Limited closed its share buyback on October 16, 2026, after deploying ₹105.99 Crore to repurchase 25,02,674 equity shares.
- Value
- ₹106.0 Cr
SIS Capital Structure Change
SIS Limited repurchased 10,706 equity shares from the open market at an average price of ₹405.37, totalling approximately ₹0.43 Crore. This report provides daily buyback details.
- Value
- ₹0.43 Cr
SIS Capital Structure Change
SIS Limited repurchased 31,000 equity shares on October 15, 2026, at an average price of ₹407.49 per share as part of its ongoing buyback program.
- Value
- ₹1.26 Cr
SIS Capital Structure Change
SIS Limited reported the daily buyback of 20,000 equity shares at an average price of ₹407.9137. The total cumulative shares bought back now stand at 24,60,968.
- Value
- ₹0.82 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.